Full-Time

CPO or Clinical Manager

Updated on 5/12/2026

Ottobock

Ottobock

1,001-5,000 employees

Provider of prosthetics, orthotics, wheelchairs, exoskeletons

No salary listed

Austin, TX, USA

In Person

Category
Medical, Clinical & Veterinary (2)
,
Requirements
  • Bachelor’s Degree or Master’s degree in Orthotics and/or Prosthetics
  • Certification in good standing with the American Board for Certification in Orthotics and/or Prosthetics or the Board of Certification/Accreditation (BOC)
  • In states where licensure is required, the ability to obtain and maintain appropriate state licensure
  • 3 to 7 years of direct patient care experience as a Board‑Certified Prosthetist/Orthotist
  • Knowledge and experience in prosthetic and/or orthotic clinical practice and related technology
  • Demonstrated experience instructing clinical and non‑clinical personnel, as well as customers, on patient care service objectives
  • Ability to communicate clearly and effectively, both verbally and in writing, with vendors, suppliers, co‑workers, and management
  • Ability to work collaboratively and contribute to a team‑based environment
  • Ability to anticipate, identify, analyze, and resolve problems and conflict
  • Excellent organizational and time‑management skills with the ability to prioritize and manage multiple tasks to completion
  • Advanced computer skills, including proficiency with Microsoft Office and databases
  • Valid driver’s license with no limitations and access to a reliable vehicle
Responsibilities
  • Manages clinical operations and clinical staff at assigned patient care facility. Clinical staff includes clinicians, technicians, and fitters.
  • Collaborates with clinicians in the evaluation and analysis of a patient’s need for prosthetic and/or orthotic services; recommend treatment options to clinicians when necessary.
  • Examines and evaluates patient's needs in relation to disease and functional loss.
  • Formulates design of prosthetic and/or orthotic devices.
  • Performs evaluation of fit (including static and dynamic alignments) to assure function, medical efficacy, and quality of work are appropriate.
  • Instructs patient in use of device.
  • Provides detailed clinical notes in patient records.
  • Trains Technicians, Residents, Fitters, and other Clinicians, as appropriate.
  • Utilizes effective materials management, quality, and performance processes to maximize device quality and medical efficacy, maintaining a proper balance with costs and operational/financial performance.
  • Meets with physicians, case managers and other referral sources to review services and capabilities; develop and enhance business relationships to identify and secure ongoing and future sources or referrals.
  • Provides complete and accurate direction and guidance to technicians responsible for fabrication of orthoses and/or prosthesis for his/her patients. Delegate responsibility and expect accountability and regular feedback.
  • Accomplishes financial objectives by forecasting requirements; Assist in preparing an annual budget.
  • Achieves and maintains professional knowledge and technical skills through continuing education.
  • Identifies and creates improvements to processes to promote efficiency and productivity. This specifically includes current "state of the art" knowledge, procedures, components, and materials including application based on diagnosis.
  • Helps ensure offices are ABC/Medicare/Labor Compliant and assist with accreditation, as necessary.
  • Complies with Corporate Compliance and HIPAA requirements.
  • Enforces all safety regulations; Compliance with Medicare and other governmental regulations; Compliance with bloodborne and Occupational Safety and Health Administration (OSHA) requirements.
  • Performs other duties or special projects as assigned.
Desired Qualifications
  • Minimum of two years in a lead or supervisory role in the healthcare industry preferred (for Clinic Manager candidates only)

Ottobock is a global producer of orthopedic technology, focusing on prosthetics, orthotics, wheelchairs, and exoskeletons. Its products range from basic devices to advanced, microprocessor-controlled prosthetics and ergonomic exoskeletons that help people move more easily and stay independent. These devices work by using sensors, motors, and smart controls to adapt to a user’s movement, pace, and terrain, providing ankle and knee assistance or full upper- and lower-limb support. compared with others, Ottobock stands out as a family-owned company with a long history, a broad international footprint in about 60 countries, a large workforce, and a strong commitment to social responsibility, including a long-running partnership with the Paralympic Games. Its core goal is to improve mobility and quality of life for people with disabilities by delivering reliable, high-quality mobility solutions.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Duderstadt, Germany

Founded

1919

Simplify Jobs

Simplify's Take

What believers are saying

  • IPO raised €702-808M in October 2025, shares surged 11% to €73.
  • $5M Blue Arbor investment advances FDA breakthrough RESTORE system.
  • SuitX acquisition in 2021 expands exoskeletons into industrial markets.

What critics are saying

  • Össur's POWER KNEE erodes C-Leg share by 15% via AI gait prediction.
  • Deren Bionics captures 25% Asia-Pacific orthotics with cheaper prosthetics.
  • Näder family succession dispute forces share sales, crashing stock 25-40%.

What makes Ottobock unique

  • Ottobock leads globally in prosthetics as world market leader since 1919.
  • Advanced microprocessor prosthetics like C-Leg set industry benchmarks.
  • Long-term Paralympic partnership drives mobility innovation worldwide.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Ottobock who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Company Match

100% company-paid short & long-term disability

Company News

Morningstar
Feb 26th, 2026
Blue Arbor secures $5M from Ottobock to advance FDA breakthrough prosthetic control system

Blue Arbor Technologies has secured a $5 million investment from Ottobock, the global prosthetics leader, to advance its RESTORE Neuromuscular Interface System. Ottobock will lead Blue Arbor's Series A financing and hold a board seat. The FDA breakthrough-designated RESTORE System provides a fully implanted neuromuscular interface connecting advanced prostheses directly to patients' residual muscles and peripheral nerves. It enables independent, simultaneous control of fingers, wrist and elbow, with trials demonstrating stable signal capture for over five years. In December 2025, surgeons at the Medical University of Vienna completed the first-in-human RESTORE procedure. Within days, the patient demonstrated functional use with an Ottobock prosthetic. Founded by Drs Paul Cederna, Theodore Kung and Alex Vaskov, Blue Arbor has been awarded over $60 million in research grants and published more than 200 peer-reviewed papers.

Business Wire
Feb 26th, 2026
Blue Arbor Technologies Announces Strategic Partnership with Ottobock and $5 Million Investment to Advance RESTORE™ Neuromuscular Interface System

Blue Arbor Technologies announces $5 million investment by Ottobock to advance RESTORE™ System, designed to enable intuitive prosthetic control

De Tijd
Oct 24th, 2025
Onward Raises €50.85M from Investors

Onward has completed its capital round, securing €50.85 million from a group of major investors.

Investing.com
Oct 17th, 2025
Ottobock IPO Shares Stabilize at €66

Ottobock SE & Co. KGaA shares have been stabilizing since their IPO on October 14, with trading starting at €66.00. The lowest price reached was €64.50 on October 17. Stabilization measures, managed by Goldman Sachs Bank Europe SE, have been conducted daily across multiple trading venues, including XETRA and the Frankfurt Stock Exchange. The base offering included 10,640,151 shares. The shares are trading under ISIN DE000BCK2223.

Bloomberg L.P.
Oct 9th, 2025
Ottobock Shares Rise After Biggest German IPO of 2025

Ottobock SE & Co. shares rose in the prosthetics firm’s debut trading session in Frankfurt on Thursday, after the biggest initial public offering in Germany in more than a year.